Related Experiment Video

Updated: Sep 11, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Monoclonal antibody-based therapy of lymphoid neoplasms: what's on the horizon?

A T Davis1

  • 1Cancer Therapy Evaluation Program, National Institutes of Health, Bethesda, MD, USA.

Seminars in Hematology
|January 9, 2001
PubMed

Insights

Monoclonal antibody therapy is rapidly advancing, with many novel agents and strategies expected in clinical practice. Future research will focus on enhancing efficacy, developing new antibody types, and exploring immune system modulation for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Monoclonal antibody therapy has seen significant advancements.
  • Numerous novel agents are in earlier stages of development.

Purpose of the Study:

  • To review emerging monoclonal antibody therapies and their potential clinical applications.
  • To explore novel strategies for enhancing antibody efficacy and function.

Main Methods:

  • Review of current research and development in monoclonal antibody therapy.
  • Analysis of novel antibodies targeting lymphoma cells.
  • Examination of new technologies for antibody generation and humanization.

Main Results:

  • Identification of novel strategies to augment monoclonal antibody efficacy.
  • Discovery of new antibodies with activity against lymphoma cells.
  • Emergence of novel antibody-based therapeutics and applications.

Conclusions:

  • The field of monoclonal antibody therapy is poised for significant growth.
  • Future developments include enhanced efficacy, new therapeutic types, and immune modulation applications.

More Related Videos

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.